Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11739-023-03510-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
First Report of Successful Rituximab Therapy in Idiopathic Sclerosing Mesenteritis.
J Community Hosp Intern Med Perspect
July 2025
Department of Rheumatology, Veterans Affairs Medical Center, White River Junction, VT, USA.
Sclerosing mesenteritis (SM) is a rare idiopathic fibroinflammatory disorder of the bowel mesentery adipose tissue. While the use of rituximab has been documented in IgG4-related SM, its effectiveness in idiopathic, IgG4-unrelated SM remains unknown. We present a case of idiopathic SM successfully managed with rituximab, suggesting that this treatment may be an option for patients who either have contraindications to or have not responded to current first-line therapies.
View Article and Find Full Text PDFIntegrated therapy reduces serum IgG4 in patients with IgG4-related sclerosing mesenteritis: A Case Report.
QJM
July 2025
Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Objectives: To evaluate the potential effectiveness of Chinese herbal medicine (CHM) as an adjunct to conventional corticosteroid therapy in the management of IgG4-related sclerosing mesenteritis.
Clinical Features And Outcome: A 61-year-old male presented with a two-month history of persistent diarrhea, anorexia, postprandial bloating, and significant weight loss. Diagnostic evaluation, including serum IgG4 measurement and tissue biopsy, confirmed a diagnosis of IgG4-related sclerosing mesenteritis.
Sclerosing mesenteritis: a case series detailing importance of early diagnosis.
J Surg Case Rep
July 2025
HCA Florida Trinity Hospital, 9330 State Rd 54, Trinity, FL 34655, United States.
Two patient cases are presented in this case series. Both patients presented with vague abdominal pain, and CT imaging showed calcified mesenteric masses. Definitive diagnoses of sclerosing mesenteritis was made on histological evaluation.
View Article and Find Full Text PDFRefractory Sclerosing Mesenteritis/Mesenteric Panniculitis Presenting With Macrophage Activation Syndrome Treated With Rituximab.
J Rheumatol
July 2025
S. Iriza, DO, Department of Rheumatology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA.
CAR Recommendations for the Management of Incidental Findings of the Spleen and Nodes in Adults.
Can Assoc Radiol J
June 2025
Department of Radiology, University of Manitoba, Winnipeg, MB, Canada.
The Canadian Association of Radiologists Incidental Findings Working Group (CAR IFWG) has developed new recommendations for the management of incidental findings of the spleen, lymph nodes, peritoneum, and mesentery, tailored to the Canadian healthcare context. This guidance addresses splenomegaly, focal splenic lesions, splenic artery aneurysms, lymphadenopathy, mesenteric panniculitis, and peritoneal nodules. Building on prior American College of Radiology (ACR) guidance and integrating recent evidence, the CAR IFWG offers a pragmatic approach emphasizing radiologic features, clinical context, and patient risk factors to minimize unnecessary follow-up.
View Article and Find Full Text PDF